DPPA3 regulates global DNA methylation by interacting with UHRF1 and DNMT1, key enzymes involved in maintenance methylation. Studies using DPPA3 antibodies have demonstrated:
DNA Demethylation: Overexpression of DPPA3 reduces DNA methylation levels, while knockdown increases methylation, particularly at transposable elements (LINEs, ERVs) .
UHRF1 Inhibition: DPPA3 binds UHRF1, displacing it from chromatin and preventing maintenance methylation. This interaction is conserved across species, including Xenopus and medaka .
DPPA3 is essential for maintaining the "2C-like" state in embryonic stem cells (ESCs), characterized by activation of MERVL retrotransposons and Zscan4:
Zscan4 Expression: DPPA3 knockdown reduces Zscan4 protein levels and 2C-like cell populations, while overexpression enhances them .
DNA Damage Response: DPPA3 co-localizes with γH2AX, a DNA damage marker, and regulates p53 levels, suggesting a role in genomic stability .
Imprinting Control: DPPA3 associates with the Dlk1-Dio3 imprinting control region (ICR) and suppresses DNMT3A binding, preventing aberrant methylation during somatic cell reprogramming .
Reprogramming Efficiency: Exogenous Dppa3 enhances reprogramming kinetics, while Dppa3-null fibroblasts fail to generate high-quality induced pluripotent stem cells (iPSCs) .
IHC: DPPA3 antibodies detect oocyte-specific staining in mouse ovaries, confirming tissue specificity .
Western Blot: Polyclonal antibodies recognize ~17.67 kDa DPPA3 bands in ESC lysates .
ELISA: Direct ELISA assays confirm antibody specificity against recombinant DPPA3 .